Pharma-X Next Conference & Awards 2027 to Unite Global Leaders Driving the Future of Healthcare and Life Sciences

Rome, Italy | March 11–12, 2027

Rome is set to welcome pharmaceutical executives, biotechnology innovators, healthcare providers, researchers, and digital health pioneers for the 2nd Edition of the Pharma-X Next Conference & Awards 2027, taking place on March 11–12, 2027, in Italy’s historic capital.

The global healthcare landscape is evolving at an unprecedented pace. Artificial intelligence is transforming drug discovery, precision medicine is reshaping patient care, biotechnology is accelerating scientific breakthroughs, and digital health solutions are redefining how healthcare is delivered. Against this backdrop, Pharma-X Next 2027 will bring together some of the world’s leading minds in pharmaceuticals, biotechnology, healthcare, MedTech, digital health, academia, and life sciences.

Following the resounding success of the inaugural edition held on May 11, 2026, the 2027 conference returns with an expanded, two-day program designed to foster cross-sector collaboration. The agenda will feature keynote presentations, fireside chats, executive panel discussions, and the prestigious Pharma-X Next Awards, creating a platform where ideas become partnerships and partnerships improve patient outcomes.

A Message from the CEO

Anas Jawed, CEO of Next Business Media and Conference Chair of Pharma-X Next 2027, has shared a welcome message ahead of the event:

“Artificial intelligence and biotechnology are not just changing how we interact with technology—they are rewriting the very blueprint of drug discovery, clinical development, and patient care. Pharma-X Next 2027 was conceived as a cross-sectoral arena where pharmaceutical giants, biotech innovators, regulators, and digital health pioneers can converge to accelerate life-saving solutions. Following the incredible momentum of our inaugural edition in May 2026, we are proud to return to Rome to foster the honest conversations and strategic partnerships necessary to tackle the healthcare challenges of tomorrow. We look forward to welcoming the global health community this March.”

Anas Jawed, Founder and CEO of Next Business Media Private Limited, brings extensive experience in organizing business events, technology platforms, and digital solutions that connect industry leaders across sectors.

Conference Agenda – Day 1 (March 11, 2027)

The first day of the conference features a packed schedule of keynotes and sessions exploring the convergence of AI, biotechnology, and next-generation therapeutics.

• 09:00 AM – 09:20 AM: KEYNOTE – Opening Ceremony & Conference Keynote. Setting the stage for innovation across pharma, AI, biotechnology, and global health.
• 09:25 AM – 09:50 AM: TALK+Q&A – AI-Driven Drug Discovery: From Molecule to Market. How generative AI and LLMs are compressing decade-long R&D timelines to under three years.
• 09:50 AM – 10:15 AM: TALK+Q&A – The Agentic AI Revolution in Healthcare Operations. Autonomous agents managing clinical workflows, patient triaging, and real-time diagnostic support.
• 10:15 AM – 10:40 AM: TALK+Q&A – Precision Oncology in the Post-Genomic Era. Liquid biopsies, multi-omic profiling, and personalised therapy selection for complex cancers.
• 10:40 AM – 11:00 AM: Coffee Break & Networking
• 11:00 AM – 11:25 AM: TALK+Q&A – Quantum Computing in Molecular Simulation. Simulating protein folding and drug-target interactions at unprecedented scale using quantum algorithms.
• 11:25 AM – 11:50 AM: TALK+Q&A – The Next Frontier of mRNA Therapeutics. Beyond vaccines—mRNA-based cancer immunotherapy, rare disease treatment, and regenerative medicine.
• 11:50 AM – 12:15 PM: TALK+Q&A – Digital Biomarkers & Wearable Health Ecosystems. Real-world evidence through smartwatches and continuous biosensors for decentralised clinical trials.
• 12:15 PM – 12:40 PM: TALK+Q&A – Blockchain for Pharmaceutical Supply Chain Integrity. End-to-end traceability and combating counterfeit drugs through decentralised ledger systems.
• 12:40 PM – 01:45 PM: Networking Lunch
• 01:45 PM – 02:10 PM: TALK+Q&A – Synthetic Biology: Engineering Life for Therapeutics. Programmable cells, gene circuits, and engineered microbiomes as next-generation drug delivery vehicles.
• 02:10 PM – 02:35 PM: TALK+Q&A – Federated Learning for Secure Multi-Site Clinical Data. Privacy-preserving AI training on distributed hospital data without centralising sensitive patient records.
• 02:35 PM – 03:00 PM: TALK+Q&A – Global Regulatory Harmonisation in the AI Age. EMA, FDA, and ICH frameworks adapting to algorithm-based medical devices and AI-generated evidence.
• 03:00 PM – 03:25 PM: TALK+Q&A – Longevity Science: Pharma’s Emerging Frontier. Senolytics, epigenetic reprogramming, and anti-ageing pipelines moving from labs into clinical settings.
• 03:25 PM – 03:45 PM: Afternoon Coffee Break
• 03:45 PM – 04:10 PM: TALK+Q&A – Decentralised Clinical Trials: Patient-Centric by Design. Remote monitoring, e-consent, and home-based visits reshaping global trial recruitment and retention.
• 04:10 PM – 04:35 PM: TALK+Q&A – Psychedelic-Assisted Therapy: Clinical Evidence & Market Outlook. Psilocybin, ketamine, and MDMA therapies entering mainstream psychiatry—regulatory pathways and scale.
• 04:35 PM – 05:00 PM: PharmaXNext Awards Ceremony — Day 1. Recognising outstanding contributions in pharmaceutical innovation, research, and digital transformation.
• 05:00 PM – 06:30 PM: Evening Networking Reception

Conference Agenda – Day 2 (March 12, 2027)

Day 2 continues the momentum with deep dives into cell and gene therapy, regulatory compliance, and the investment landscape shaping global health.

• 09:00 AM – 09:20 AM: KEYNOTE – Day 2 Opening: Shaping the Future of Global Health. A forward-looking address bridging policy, innovation, and sustainability across pharma and biotech.
• 09:25 AM – 09:50 AM: TALK+Q&A – LLMs as Clinical Decision Support Tools. GPT-class models in radiology, diagnosis assistance, and patient communication—evidence and ethics.
• 09:50 AM – 10:15 AM: TALK+Q&A – Advanced Drug Delivery: Nanoparticles, Exosomes & Beyond. Engineering next-generation carriers for targeted delivery to tumours, the CNS, and gene therapy payloads.
• 10:15 AM – 10:40 AM: TALK+Q&A – Cell & Gene Therapy: Scaling from Bench to Bedside. Manufacturing challenges, cost reduction strategies, and reimbursement models for one-time curative therapies.
• 10:40 AM – 11:00 AM: Coffee Break & Networking
• 11:00 AM – 11:25 AM: TALK+Q&A – GLP-1 Agonists & the Metabolic Disease Pipeline. Beyond weight loss—cardiovascular, renal, and neurological benefits driving the next wave of blockbusters.
• 11:25 AM – 11:50 AM: TALK+Q&A – Sustainability & Green Chemistry in Pharma Manufacturing. Solvent reduction, continuous flow chemistry, and net-zero manufacturing targets across the value chain.
• 11:50 AM – 12:15 PM: TALK+Q&A – Antimicrobial Resistance: Innovation Strategies for a Silent Pandemic. Phage therapy, novel antibiotic classes, and AI-powered pathogen surveillance in the fight against AMR.
• 12:15 PM – 12:40 PM: TALK+Q&A – Digital Health Regulation: EU AI Act & Medical Device Regulation. Compliance pathways for AI-powered medical devices and SaMD under Europe’s evolving regulatory landscape.
• 12:40 PM – 01:45 PM: Networking Lunch
• 01:45 PM – 02:10 PM: TALK+Q&A – Neurotechnology & Brain-Computer Interfaces in Medicine. Implantable and non-invasive BCIs for neurological disorders, mental health, and cognitive augmentation.
• 02:10 PM – 02:35 PM: TALK+Q&A – AI-Powered Pathology & Imaging Diagnostics. Foundation models for histopathology and radiology achieving expert-level diagnostic accuracy at scale.
• 02:35 PM – 03:00 PM: TALK+Q&A – Microbiome Therapeutics: The Next Drug Class. Live biotherapeutic products, FMT, and postbiotics entering regulatory-approved pipelines globally.
• 03:00 PM – 03:25 PM: TALK+Q&A – HealthTech Investment Landscape: Where Capital Is Flowing in 2027. Venture, private equity, and strategic pharma investment trends across AI, biotech, and digital health.
• 03:25 PM – 03:45 PM: Afternoon Coffee Break
• 03:45 PM – 04:10 PM: TALK+Q&A – Global Health Equity: Bridging the Innovation Access Gap. Open-science models, tiered pricing, and technology transfer strategies for emerging-market healthcare.
• 04:10 PM – 04:35 PM: TALK+Q&A – The Future of Pharmaceutical AI: What Comes After 2027? Forecasting the next decade: autonomous drug design, AI-native CROs, and the fully digital clinical trial.
• 04:35 PM – 05:00 PM: AWARDS – Closing Keynote & PharmaXNext Awards Ceremony – Day 2. Closing reflections, innovation highlights, and the prestigious PharmaXNext Excellence Awards.
• 05:00 PM – 06:00 PM: Farewell Networking & Conference Close

Why Attend Pharma-X Next 2027

What distinguishes the Pharma-X Next programme, according to organizers, is its holistic, interdisciplinary approach. Rather than focusing on one vertical, the agenda is designed to bridge gaps between advanced therapeutics, AI operations, regulatory frameworks, and patient-centric care.

Attendees will gain insights into:

• Next-Gen Drug Development: From generative AI in R&D to mRNA and cell therapies.
• Regulatory & Compliance: Navigating the EU AI Act, FDA guidelines, and global harmonisation.
• Digital Health & Data: Leveraging federated learning, blockchain supply chains, and wearable biomarkers.
• Investment & Scaling: Understanding where capital is flowing and how to scale curative therapies from bench to bedside.

Networking, Awards, and Industry Engagement

Beyond the educational sessions, Pharma-X Next provides robust opportunities for high-level networking. The conference will culminate in the Pharma-X Next Awards Ceremony on both evenings, providing a platform to recognize exceptional organizations and individuals advancing healthcare through innovation, leadership, research excellence, and transformative technologies.

Event Details

• Event: Pharma-X Next Conference & Awards 2027 – 2nd Edition
• Dates: March 11–12, 2027
• Venue: Rome, Italy
• Website: https://pharmaxnext.com/

Join Pharma-X Next 2027

As healthcare challenges become increasingly interconnected, innovation can no longer happen in isolation. Pharma-X Next serves as a catalyst for knowledge exchange, strategic partnerships, and the advancement of healthcare worldwide.

Professionals interested in speaking opportunities, sponsorship packages, exhibition space, delegate participation, or media partnerships are encouraged to become part of this international platform.

For speaking opportunities, delegate registrations, sponsorship packages, exhibition bookings, or any other event-related inquiries, please contact:

Diwakar Chandra Gour
Email: [email protected]